Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis-Reference-Cited by-同舟云学术

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

Published:2000-07 Issue:13 Volume:7 Page:1156-1165
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Hyde SC,Southern KW,Gileadi U,Fitzjohn EM,Mofford KA,Waddell BE,Gooi HC,Goddard CA,Hannavy K,Smyth SE,Egan JJ,Sorgi FL,Huang L,Cuthbert AW,Evans MJ,Colledge WH,Higgins CF,Webb AK,Gill DR

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301212.pdf

Reference35 articles.

1. Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA Science 1989 245: 1066–1073

2. Quinton PM . Physiological basis of cystic fibrosis: a historical perspective Physiol Rev 1999 79: (Suppl.) S3–S22

3. Pilewski JM, Frizzell RA . Role of CFTR in airway disease Physiol Rev 1999 79: (Suppl.) S215–S255

4. Drumm ML et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer Cell 1990 62: 1227–1233

5. Hyde SC et al. Correction of the ion-channel defect in CF transgenic mice by gene therapy Nature 1993 362: 250–255

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines;Advanced Drug Delivery Reviews;2024-06

2. Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing;Molecular Therapy - Methods & Clinical Development;2023-12

3. In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations;Genes;2022-11-27

4. Gene therapy for cystic fibrosis: Challenges and prospects;Frontiers in Pharmacology;2022-10-11

5. Lipid‐based nucleic acid therapeutics with in vivo efficacy;WIREs Nanomedicine and Nanobiotechnology;2022-09-30